King Signs On To Develop Pain Therapeutics’ Abuse-Resistant Oxycodone
This article was originally published in The Pink Sheet Daily
Executive Summary
The companies intend to file an NDA for the abuse-resistant oxycodone product Remoxy in 2007; King will fund Phase III.